To further investigate whether a causal relationship exists between EpCAM expression and chemotherapeutic response, we analyzed 52 patients with ovarian cancer who had undergone platinum-based chemotherapy, except for cases achieving complete surgery, defined as no visible residual tumors. The gene discussed is EPCAM; the disease is ovarian cancer.